These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15935135)

  • 1. The impact of anxiety and mood disorders on physical disease: the worried not-so-well.
    Sobel RM; Markov D
    Curr Psychiatry Rep; 2005 Jun; 7(3):206-12. PubMed ID: 15935135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functions.
    Cameron OG
    Essent Psychopharmacol; 2006; 7(1):24-34. PubMed ID: 16989290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis.
    Wardenaar KJ; Vreeburg SA; van Veen T; Giltay EJ; Veen G; Penninx BW; Zitman FG
    Biol Psychiatry; 2011 Feb; 69(4):366-73. PubMed ID: 21030010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary cortisol levels and the 2-year course of depressive and anxiety disorders.
    Vreeburg SA; Hoogendijk WJ; DeRijk RH; van Dyck R; Smit JH; Zitman FG; Penninx BW
    Psychoneuroendocrinology; 2013 Sep; 38(9):1494-502. PubMed ID: 23313277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurobiological basis of mixed depression-anxiety states.
    Gulley LR; Nemeroff CB
    J Clin Psychiatry; 1993 Jan; 54 Suppl():16-9. PubMed ID: 8093884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological and neuroendocrinological characteristics associated with depressive symptoms in breast cancer patients at the initial cancer diagnosis.
    Seok JH; Kim LS; Hong N; Hong HJ; Kim SJ; Kang HJ; Jon DI
    Gen Hosp Psychiatry; 2010; 32(5):503-8. PubMed ID: 20851271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression.
    Young EA; Abelson JL; Cameron OG
    Biol Psychiatry; 2004 Jul; 56(2):113-20. PubMed ID: 15231443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental history of depression or anxiety and the cortisol awakening response.
    Vreeburg SA; Hartman CA; Hoogendijk WJ; van Dyck R; Zitman FG; Ormel J; Penninx BW
    Br J Psychiatry; 2010 Sep; 197(3):180-5. PubMed ID: 20807961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and long-term mental and physical sequelae in the aftermath of traumatic exposure - some remarks on "the body keeps the score".
    Kapfhammer HP
    Psychiatr Danub; 2018 Sep; 30(3):254-272. PubMed ID: 30267517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive behavior and hyperactive adrenocortical function.
    Kocsis JH; Davis JM; Katz MM; Koslow SH; Stokes PE; Casper R; Redmond DE
    Am J Psychiatry; 1985 Nov; 142(11):1291-8. PubMed ID: 4061688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
    Lemus CZ; Asnis GM; Halbreich U; Harkavy Friedman JM; Van Praag HM; Rubinson E; Eisenberg J
    J Affect Disord; 1987; 12(3):219-21. PubMed ID: 2956306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic activation of NPFFR2 stimulates the stress-related depressive behaviors through HPA axis modulation.
    Lin YT; Liu TY; Yang CY; Yu YL; Chen TC; Day YJ; Chang CC; Huang GJ; Chen JC
    Psychoneuroendocrinology; 2016 Sep; 71():73-85. PubMed ID: 27243477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing depression in patients with chronic facial pain.
    Korszun A; Ship JA
    J Am Dent Assoc; 1997 Dec; 128(12):1680-6. PubMed ID: 9415765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression and cancer: mechanisms and disease progression.
    Spiegel D; Giese-Davis J
    Biol Psychiatry; 2003 Aug; 54(3):269-82. PubMed ID: 12893103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current perspectives of the roles of the central norepinephrine system in anxiety and depression.
    Goddard AW; Ball SG; Martinez J; Robinson MJ; Yang CR; Russell JM; Shekhar A
    Depress Anxiety; 2010 Apr; 27(4):339-50. PubMed ID: 19960531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome, activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in depressive disorder.
    Martinac M; Pehar D; Karlović D; Babić D; Marcinko D; Jakovljević M
    Acta Clin Croat; 2014 Mar; 53(1):55-71. PubMed ID: 24974667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional somatic syndromes, anxiety disorders and the upper airway: a matter of paradigms.
    Gold AR
    Sleep Med Rev; 2011 Dec; 15(6):389-401. PubMed ID: 21295503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What does the dexamethasone suppression test identify?
    Krishnan KR; France RD; Pelton S; McCann UD; Manepalli AN; Davidson JR
    Biol Psychiatry; 1985 Sep; 20(9):957-64. PubMed ID: 4027315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA; Hoogendijk WJ; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Smit JH; Zitman FG; Penninx BW
    Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers.
    Vogel SWN; Bijlenga D; Verduijn J; Bron TI; Beekman ATF; Kooij JJS; Penninx BWJH
    Psychoneuroendocrinology; 2017 May; 79():31-39. PubMed ID: 28249186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.